We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Wellcome 4.625% | LSE:57MC | London | Bond |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.55 | 0.57% | 97.00 | 95.30 | 98.70 | 0 | 16:35:14 |
RNS Number:8647P The Wellcome Trust 19 January 2007 The Wellcome Trust and Wellcome Trust Finance plc have today published their 2006 Annual Reports and Financial Statements. These are available from the Trust's website www.wellcome.ac.uk. Bill Castell, chairman of the Wellcome Trust, said: 'Sir Henry Welcome's last will and testament established the Wellcome Trust in 1936 and since then it has been a force for the advancement of our understanding of human and animal health and disease. This potential has grown over the last decade with the significant increases we have seen in our endowment as our portfolio diversified. In the last financial year to 30 September 2006, expenditure on charitable activities in support of our mission totalled #484 million. This was made possible by the good returns on our investment portfolio, where we achieved an overall return of 12.8%, and the investment asset base rose to #13.9 billion (including the proceeds of the #550 million bond issue in July 2006). There has been important diversification of the portfolio during the year, with increases in the use of hedge funds, the instigation of an active currency strategy, and a reduction in equities managed by UK managers. Our investment portfolio was further enhanced when, in July 2006, we became both the only UK domiciled non-public sector organisation with a AAA/Aaa credit rating and the first UK charity to issue listed bonds. The #550 million bond issue should enable us to generate more income over the long term to support our mission. Basic research underpins future discovery and application. The support of investigator led research and career initiatives therefore remains the single biggest element of our funding portfolio. The primary focus of this activity is in the UK, where we provided #278 million during the financial year to support biomedical research. Our focus over the next year will remain to fund the best people, with the best ideas, in the best environments and to create the investment returns which we need to provide the funds. We expect to see growth in our funding for both clinical research and our research activities overseas. Another key activity will be the preparation for the opening next summer of Wellcome Collection at 183 Euston Road in London and ensuring its ongoing success. There is much to be done globally in facing the challenges to the health of humankind and we are looking forward to the opportunities and challenges the year will no doubt present.' 215 Euston Road London NW1 2BE UK T+44 (0)20 7611 8866 F+44 (0)20 7611 8416 www.wellcome.ac.uk Registered charity No.210183 Trustee; The Wellcome Trust Limited Registered in England No.2711000 Registered office 215 Euston Road London NW1 2BE This information is provided by RNS The company news service from the London Stock Exchange END MSCILFVRLIIALID
1 Year Wellcome 4.625% Chart |
1 Month Wellcome 4.625% Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions